Stock listing

Dusseldorf:B43 First Tracks Biotherapeutics, Inc. Aktie

German listing (Dusseldorf) of First Tracks Biotherapeutics, Inc. · home listing NASDAQ:TRAX

Follow First Tracks Biotherapeutics, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:TRAX

$36.04 USD +1.91 (+5.6%)

Close on Oct 15, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:TRAX

Ticker
Dusseldorf:B43
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Dusseldorf
Currency
USD

What changed lately

Latest news

All First Tracks Biotherapeutics, Inc. news

Financings

  • Private placement of shares of common stock

    Oct 15, 2026

    Announced: about US$200M · US$32.75 a share · Leerink Partners +3

    Dealers: Leerink Partners, Piper Sandler, UBS Investment Bank, Wells Fargo Securities

    Buyers: Affinity Asset Advisors, LLC; First Light Asset Management; Sirenia Capital Management LP; TCGX; Trails Edge Capital Partners; Vestal Point Capital

    Use of proceeds: General corporate purposes, including clinical development of ANB033, a CD122 antagonist

    Announced Oct 15, 2026

Read by 6ix AI from the company's releases

Decks

First Tracks Biotherapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
8 in the last 12 months · 8 in all · newest Oct 15, 2026 · oldest 2026
Decks
1 deck · latest Oct 13, 2026

Where First Tracks Biotherapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:TRAX · Home listingNASDAQUnited StatesUSD
BMV:TRAXBMVMexicoMXN
BOATS:TRAXBOATSUnited StatesUSD
BIVA:TRAXBIVAMexicoMXN
Dusseldorf:B43 · This pageDusseldorfGermanyUSD
Hamburg:B43HamburgGermanyEUR

Log in to ask 6ix AI your own questions about First Tracks Biotherapeutics, Inc.